Huh?
ASX: PAR ($580M) is Phase 2/3 CLINICAL and only NOW proudly submitting their "FIRST IND WITH USA FDA"
https://www.asx.com.au/asxpdf/20190807/pdf/4478rh9k2g1rdc.pdf
Can quote dozens of companies in the exact same boat. You should be responsible for false and misleading information here
Huh? ASX: PAR ($580M) is Phase 2/3 CLINICAL and only NOW proudly...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.5¢ |
Change
0.005(0.85%) |
Mkt cap ! $121.3M | |||
| Open | High | Low | Value | Volume |
| 59.0¢ | 59.5¢ | 58.0¢ | $30.44K | 51.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.5¢ | 14739 | 4 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| RCE (ASX) Chart |